Prognostic value of PD-L1 expression and CD68 macrophages in tumor nest of patients with primary gastric cancer

被引:2
作者
Zou, Yunlian [1 ,2 ]
Wang, Jinli [2 ,3 ]
Zhang, Jinping [1 ,2 ]
Guo, Qiang [2 ,3 ]
Song, Zhengji [2 ,3 ,4 ]
Tang, Hui [2 ,3 ,4 ]
机构
[1] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Affiliated Hosp, Dept Hematol, Kunming 650032, Yunnan, Peoples R China
[2] Kunming Univ Sci & Technol, Med Fac, Kunming 650504, Yunnan, Peoples R China
[3] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Dept Gastroenterol, Affiliated Hosp, Kunming 650032, Yunnan, Peoples R China
[4] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Affiliated Hosp, Dept Gastroenterol, 157 Jinbi Rd, Kunming 650032, Yunnan, Peoples R China
基金
中国国家自然科学基金;
关键词
gastric cancer; multiplex immunohistochemistry; programmed death receptor ligand 1; cluster of differentiation 68; prognosis biomarker; DEATH-LIGAND; 1; INFILTRATING LYMPHOCYTES; SIGNIFICANT PREDICTOR; CD133; EXPRESSION; SURVIVAL; OVEREXPRESSION; PROGRESSION; CARCINOMA; PATHWAY; MARKER;
D O I
10.3892/ol.2023.14153
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The programmed death receptor 1/programmed death receptor ligand 1 axis (PD-1/PD-L1) is involved in tumor immune escape and is a potential prognostic biomarker and anti-tumor immunotherapy target in patients with gastric cancer (GC). However, the results of studies obtained in recent years have been inconsistent. The present study aimed to determine the possible predictive significance of PD-L1 in conjunction with three proteins linked with PD-L1 regulation in patients with primary GC. In the present study, the PD-L1, human epidermal growth factor receptor 2 (HER2), cluster of differentiation (CD)133 and microphage-associated CD68 expression levels were identified by multiplexed immunohistochemistry and assessed by automated pathological analysis system in 93 GC tumors and neighboring normal tissues arrayed on the same tissue microarray. All four proteins were statistically analyzed in relation to the clinicopathological characteristics. The expression levels of HER2, CD133 and CD68 were considerably higher in cancer tissues compared with neighboring normal tissues (P<0.05), however, the reverse trend was detected for PD-L1 expression (P=0.0577), particularly in tumor nest (TN; P<0.05). There was no significant correlation between the HER2 and CD133 expression levels and clinicopathological factors. However, significant relationships were found between PD-L1 expression and the TNM stage, pathological differentiation and survival status of patients (P<0.05). Moreover, survival time was prolonged in individuals with elevated PD-L1 expression in TN and GC tissues, but no significant correlation was identified (P=0.0881). The CD68 expression level in tumor stroma, but not in TN, was significantly correlated with poor pathological differentiation in patients with GC (P<0.05). However, PD-L1+CD68+ macrophages were strongly related to lower tumor size (diameter <5 cm), early TNM stage (stage I+II), good pathological differentiation and overall survival in TN (P<0.05). In conclusion, PD-L1+CD68+ macrophage infiltration in TN might be a potential indicator of prognosis in patients with primary GC and merits further investigation.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Prognostic value of PD-L1 expression in patients with primary solid tumors
    Xiang, Xiao
    Yu, Peng-Cheng
    Long, Di
    Liao, Xiao-Li
    Zhang, Sen
    You, Xue-Mei
    Zhong, Jian-Hong
    Li, Le-Qun
    ONCOTARGET, 2018, 9 (04) : 5058 - 5072
  • [2] CD68 positive and/or CD163 positive tumor-associated macrophages and PD-L1 expression in breast phyllodes tumor
    Shin, Eunah
    Kim, Hye Min
    Koo, Ja Seung
    BREAST CANCER RESEARCH AND TREATMENT, 2025, 209 (02) : 261 - 273
  • [3] Interferon-γ induced PD-L1 expression and soluble PD-L1 production in gastric cancer
    Imai, Yushi
    Chiba, Tetsuhiro
    Kondo, Takayuki
    Kanzaki, Hiroaki
    Kanayama, Kengo
    Ao, Junjie
    Kojima, Ryuta
    Kusakabe, Yuko
    Nakamura, Masato
    Saito, Tomoko
    Nakagawa, Ryo
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Tawada, Akinobu
    Matsumura, Tomoaki
    Nakagawa, Tomoo
    Kato, Jun
    Kotani, Ai
    Matsubara, Hisahiro
    Kato, Naoya
    ONCOLOGY LETTERS, 2020, 20 (03) : 2161 - 2168
  • [4] Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
    Shin, Kabsoo
    Kim, Joori
    Park, Se Jun
    Lee, Myung Ah
    Park, Jae Myung
    Choi, Myung-Gyu
    Kang, Donghoon
    Song, Kyo Young
    Lee, Han Hong
    Seo, Ho Seok
    Lee, Sung Hak
    Kim, Bohyun
    Kim, Okran
    Park, Juyeon
    Kang, Nahyeon
    Kim, In-Ho
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [5] The Prognostic Value of Gastric Immune Prognostic Index in Gastric Cancer Patients Treated With PD-1/PD-L1 Inhibitors
    Chen, Li
    Zhao, Ruihu
    Sun, Hao
    Huang, Rong
    Pan, Hongming
    Zuo, Yanjiao
    Zhang, Lele
    Xue, Yingwei
    Li, Xingrui
    Song, Hongjiang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] The prognostic value of tumor PD-L1 status in patients with metastatic prostate cancer
    Matveev, V. B.
    Kirichek, A. A.
    Safronova, V. M.
    Kokosadze, N., V
    Khalmurzaev, O. A.
    Kamolov, B. Sh
    Liubchenko, L. N.
    ONKOUROLOGIYA, 2019, 15 (01): : 57 - 65
  • [7] Clinicopathological and Prognostic Significance of MSI Status and PD-L1 Expression in Turkish Patients with Gastric Cancer
    Bahsi, Seyma
    Yildiz, Ibrahim
    Erdamar, Sibel
    Goksel, Suha
    Tozun, Nurdan
    Aytac, Erman
    Demir, Gokhan
    Er, Ozlem
    Baca, Bilgi
    Karahasanoglu, Tayfun
    Hamzaoglu, Ismail
    Ozer, Leyla
    Bozkurt, Mustafa
    Uras, Cihan
    Bayoglu, Ibrahim Vedat
    Dulgeroglu, Onur
    Ince, Umit
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2021, 31 (04): : 246 - 254
  • [8] PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients
    Kim, Hye Ryun
    Ha, Sang-Jun
    Hong, Min Hee
    Heo, Su Jin
    Koh, Yoon Woo
    Choi, Eun Chang
    Kim, Eun Kyung
    Pyo, Kyoung Ho
    Jung, Inkyung
    Seo, Daekwan
    Choi, Jaewoo
    Cho, Byoung Chul
    Yoon, Sun Och
    SCIENTIFIC REPORTS, 2016, 6
  • [9] PD-1 and PD-L1 co-expression predicts favorable prognosis in gastric cancer
    Wu, Yanhua
    Cao, Donghui
    Qu, Limei
    Cao, Xueyuan
    Jia, Zhifang
    Zhao, Tiancheng
    Wang, Quan
    Jiang, Jing
    ONCOTARGET, 2017, 8 (38) : 64066 - 64082
  • [10] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112